RHEUMATOID FACTOR (RF) OR ANTI-CYCLIC CITRULLINATED PEPTIDE (aCCP) SEROPOSITIVITY IN RHEUMATOID ARTHRITIS (RA) PATIENTS MAY ENHANCE CLINICAL RESPONSE TO RITUXIMAB

被引：0
|
作者：
Isaacs, John D. [1 ]
Olech, Ewa [2 ]
Tak, Paul P. [3 ]
Deodhar, Atul [4 ]
Keystone, Edward [5 ]
Emery, Paul [6 ]
Yocum, David [7 ]
Hessey, Eva [8 ]
Read, Simon [8 ]
机构：
[1] Newcastle Univ, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England
[2] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
[3] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[5] Univ Toronto, Toronto, ON, Canada
[6] Leeds Gen Infirm, Leeds, W Yorkshire, England
[7] Genentech Inc, San Francisco, CA 94080 USA
[8] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
来源：
RHEUMATOLOGY | 2010年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I94 / I94
页数：1
相关论文
共 50 条
  • [11] Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil
    Goeldner, Isabela
    Skare, Thelma L.
    Reason, Iara T. de Messias
    Nisihara, Renato M.
    Silva, Marilia B.
    da Rosa Utiyama, Shirley R.
    RHEUMATOLOGY, 2010, 49 (08) : 1590 - 1593
  • [12] CLINICAL RESPONSES OF SARILUMAB BASED ON RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Emery, Paul
    van Hoogstraten, Hubert
    Mangan, Erin K.
    van Adelsberg, Janet
    Fan, Chunpeng
    Kivitz, Alan
    Pinheiro, Geraldo da R. C.
    Huizinga, Tom W.
    RHEUMATOLOGY, 2017, 56 : 140 - 141
  • [13] Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and comorbidity
    Stamenkovic, Doris
    Stiglic-Rogoznica, Nives
    Stiglic, Mirna
    Avancini-Dobrovic, Viviana
    Grubisic-Karavanic, Vlasta
    Frlan-Vrgoe, Ljubinka
    Radovic, Endi
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 706 - 707
  • [14] Clinical Significance of Combined Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Assays in Rheumatoid Arthritis Diagnosis
    Cao, Qingmei
    Wang, Yanfeng
    Jing, Yuanyuan
    ARCHIVES OF RHEUMATOLOGY, 2015, 30 (02): : 104 - 108
  • [15] Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
    Li Bo
    Ye Zhizho
    Guo Fenlia
    Li Jianso
    Pediatric Rheumatology, 6 (Suppl 1)
  • [16] Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis
    Vallbracht, I
    Rieber, J
    Oppermann, M
    Förger, F
    Siebert, U
    Helmke, K
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) : 1079 - 1084
  • [17] A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis
    Cho, Sun Young
    Kang, So Young
    Lee, Hee Joo
    Lee, Woo In
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2008, 28 (01): : 39 - 45
  • [18] ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY AND RHEUMATOID FACTOR AND THE RELATIONSHIP BETWEEN PERIODONTITIS AND RHEUMATOID ARTHRITIS
    Bolyarova-Konova, Theodora Nikolaeva
    Stefanov, Lyubomir Deyanov
    Kolarov, Zlatimir Gospodinov
    Grozdanova, Radoslava Emilova
    Nikolova, Maria Hristianova
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2022, 75 (03): : 451 - 457
  • [19] Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
    De Rycke, L
    Verhelst, X
    Kruithof, E
    Van den Bosch, F
    Hoffman, IEA
    Veys, EM
    De Keyser, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 299 - 302
  • [20] Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients
    Sulaiman, Farah Nadiah
    Wong, Kah Keng
    Ahmad, Wan Aireene Wan
    Ghazali, Wan Syamimee Wan
    MEDICINE, 2019, 98 (12)
12345